<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>509-TETRABENAZINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="TETRABENAZINE" rxcui="10390">
<ATC code="N07XX06" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="DOPAMINERGICS" code="N04B-002" /></DRUG2>
<DESCRIPTION>Reciprocal antagonism between the dopaminergic and the tetrabenazine</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>509-TETRABENAZINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="TETRABENAZINE" rxcui="10390">
<ATC code="N07XX06" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="IRREVERSIBLE MONOAMINE OXIDASE INHIBITORS (MAOI)" code="N06AF0" /></DRUG2>
<DESCRIPTION>Risk of hypertensive crises. Because of the duration of the action of the MAOI, this interaction is still theoretically possible two weeks after the MAOI is stopped</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>509-TETRABENAZINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name=" TETRABENAZINE" rxcui="10390">
<ATC code="N07XX06" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="LEVODOPA" rxcui="6375">
<ATC code="N04BA01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Reciprocal antagonism between the levodopa and the tetrabenazine</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
</INTERACTIONS>
